|
Real-World Outcomes of Patients Starting Intravenous and Transitioning to Subcutaneous Vedolizumab in Inflammatory Bowel Disease |
|
|
|
Title: |
Real-World Outcomes of Patients Starting Intravenous and Transitioning to Subcutaneous Vedolizumab in Inflammatory Bowel Disease |
Author: |
Lamichhane, N. Melas, N. Bergqvist, V. , Ekholm, N.-P. Olén, O. Ludvigsson, J. F. Hjortswang, H. Marsal, J. Eriksson, C. Halfvarson, J. |
Appeared in: |
Digestive diseases and sciences |
Paging: |
Volume 69 () nr. 6 pages 2175-2183 |
Year: |
2024-04-18 |
Contents: |
|
Publisher: |
Springer US, New York |
Source file: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|